Home › Migraine › Virginia › Charlottesville
Migraine clinical trials in Charlottesville, VA
3 studies for Migraine are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RecruitingPhase 3
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Concord, CA8 studies
- Miami, FL8 studies
- Philadelphia, PA8 studies
- Austin, TX8 studies
- Washington, DC7 studies
- Houston, TX7 studies
- Omaha, NE7 studies
- Amherst, NY7 studies
- Tampa, FL6 studies
- Charlotte, NC6 studies
- Salt Lake City, UT6 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Endometrial Cancer14 studies
- Lung Cancer13 studies
- Metastatic Cancer13 studies
- Heart Failure11 studies
- Ischemic Stroke10 studies
- Ovarian Cancer10 studies
- Colorectal Cancer10 studies
- Type 1 Diabetes9 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.